Mai Shi
0000-0002-2798-3268
Publication & Citation Trends
Publications
0 total
TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma
Cited by 4
Semantic Scholar
CircATF6 inhibits hepatocellular carcinoma progression by suppressing calreticulin-mediated Wnt/β-catenin signaling pathway.
Cited by 3
Semantic Scholar
Two somatic mutations in the androgen receptor N-terminal domain are oncogenic drivers in hepatocellular carcinoma OA
Cited by 1
Semantic Scholar
Nuclear localization of TET2 requires β-catenin activation and correlates with favourable prognosis in colorectal cancer OA
Cited by 11
Semantic Scholar
PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial–mesenchymal transition in bladder cancer OA
Cited by 20
Semantic Scholar
Abstract LB154: Circ0003039 interacts with calreticulin to inhibit the progression of hepatocellular carcinoma by suppressing wnt/beta-catenin signaling pathway
Cited by 0
Semantic Scholar
STRESS granule-associated RNA-binding protein CAPRIN1 drives cancer progression and regulates treatment response in nasopharyngeal carcinoma OA
Cited by 9
Semantic Scholar
Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma OA
Cited by 4
Semantic Scholar
Research Topics
Diabetes Treatment and Management
(21)
Metabolism, Diabetes, and Cancer
(14)
Diabetes, Cardiovascular Risks, and Lipoproteins
(12)
Epigenetics and DNA Methylation
(12)
Liver Disease Diagnosis and Treatment
(9)
Affiliations
Shandong University
Beijing University of Chinese Medicine
Chinese University of Hong Kong
Second Military Medical University
Nantong University